[Colivelin--drug therapy for patients with Alzheimer's disease].
Matsuoka
Masaaki
M
sakimatu@tokyo-med.ac.jp
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D015195:Drug Design; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000008:administration & dosage* / Q000502:physiology; D053614:Janus Kinase 2 / Q000502:physiology; D009419:Nerve Tissue Proteins / Q000502:physiology; D050796:STAT3 Transcription Factor / Q000502:physiology; D009435:Synaptic Transmission
C508523:Colivelin; D047908:Intracellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C427211:humanin; C507924:JAK2 protein, human; D053614:Janus Kinase 2